Analysis of the Cardiac Biomarker Diagnostics Market

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.

Table of Contents

1. Executive Summary
Key Findings
Competitive Landscape
Scope and Segmentation
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Nanomix (POCT)
Critical Diagnostics (Lab-based)
CardioDx (POCT)
3 Big Predictions
2. Market Overview
Cardiac Diagnostics Industry Overview
Cardiac Biomarkers Diagnostics Overview
Market Background
Prevalence Rate
Cardiac Diagnostics Overview
Testing Procedure
Factors Influencing Adoptability of Tests
Defining Healthcare Trends in the Future
3. Competitive Playbook
New Market Opportunities
Solutions Provided by Top Companies
Important Partnerships—Cardiac Biomarker IVD Diagnostics
Emerging Biomarkers for MI and Clinical Strength
4. Emerging Biomarkers
LDTs—Role in Cardiac Diagnostics
Other Emerging Biomarkers
5. Driver and Restraints—Total Cardiac Biomarker Diagnostics Market
Market Drivers
A high prevalence rates
The increasing use of biomarkers
The HF market segment is expected to gain popularity
There is a focus on precision medicine
Market Restraints
Reimbursement cuts
Laboratory consolidation
A tougher regulatory environment
Increasing competition from other technologies, including mobile diagnosis
6. Forecasts and Trends—Total Cardiac Biomarker Diagnostics Market
Market Engineering Measurements
Revenue Forecast
Percent Revenue Breakdown by Segments
Segment Lifecycle Analysis
7. Competitive Environment
Market Share
Market Share Analysis
Overall Market Share Analysis
Top Competitors
Alere
Roche Diagnostics
Siemens Healthcare
Abbott
Beckman Coulter
8. POCT Segment Analysis
Market Engineering Measurements
Revenue Forecast
POCT—Segment Share
Segment Share Analysis
Competitive Value Matrix
Top POCT Devices in the US Market
Competitive Product Analysis
9. Lab-based Segment Analysis
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Disease Type
Growth Rate by Cardiac Disease
Product Portfolio
Pricing Trends and Forecast
Segment Share
Segment Share Analysis
Competitive Value Matrix
10. The Full Picture—Cardiac Diagnostics Industry Overview
Cardiac Diagnostics Industry Overview
Partnership Trends—Medical Device Diagnostics
11. Cardiac Imaging Diagnostics
Industry Overview
Industry Overview by Application
OEMs
Healthcare Providers
Regulatory Bodies
Industry Overview by Application
Cardiac Imaging and Monitoring
Interventional Cardiology
Monitoring
Imaging and Diagnostics
New Market Opportunities
Imaging Technology—Role in Patient Continuum
12. ECG in Cardiac Diagnostics
Industry Overview
Cardiac Monitoring by Application
New Market Opportunities
ECG Technology—Role in Patient Continuum
13. Opportunities
Opportunities—Companion Diagnostics
Digital Health and Diagnostics Inter Convergence Model—Cardiac Diagnostics
Opportunity
Convergence of Imaging and IVD
Key Companies to Watch
14. The Last Word
3 Big Predictions
Legal Disclaimer
15. Appendix
List of Others
Market Engineering Methodology

Infographic



List of Figures & Charts

1. Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024
2. Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014
3. Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014
4. Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011–2014
5. Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US, 2014
6. Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015–2021
7. Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015–2021
8. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
9. Total Cardiac Biomarker Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
10. Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
11. Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014
12. POCT Segment: Market Engineering Measurements, US, 2014
13. POCT Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
14. POCT Segment: Top 10 Products, US, 2014
15. Lab-based Tests Segment: Market Engineering Measurements, US, 2014
16. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
17. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
18. Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011–2014
19. Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
20. Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014
21. Total Cardiac Diagnostics Industry: ECG, US, 2014
22. Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014
23. Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013–2015


1. Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014
2. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
3. Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014
4. Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014
5. Cardiac Diagnostics Prevalence Rate, US, 2009–2020
6. Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014
7. Total Cardiac Biomarker Diagnostics Market: Adoptability of Biomarker Tests, US, 2014
8. Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014
9. Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014
10. Cardiac Diagnostics Prevalence Rate, US, 2009–2020
11. Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011–2021
12. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014
13. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021
14. Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014
15. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014
16. POCT Segment: Revenue Forecast, US, 2011–2021
17. POCT Segment: Percent Revenue Breakdown, US, 2014
18. POCT Segment: Competitive Analysis, US, 2014
19. POCT Segment: Product Analysis, US, 2014
20. Lab-based Tests Segment: Revenue Forecast, US, 2011–2021
21. Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011–2021
22. Lab-Based Tests Segment: Growth Rate by Cardiac Disease, US, 2011–2021
23. Lab-based Tests Segment: Product Analysis, US, 2014
24. Lab-based Tests Segment: Average Price, US, 2009–2021
25. Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014
26. Lab-based Tests Segment: Competitive Analysis, US, 2014
27. Total Cardiac Diagnostics Market: Industry Overview, US, 2014
28. Total Cardiac Diagnostics Industry: Overview by Application, US, 2014
29. Total Cardiac Diagnostics Market: Patient Continuum, US, 2014
30. Total Cardiac Monitoring Market: Market Segmentation, US, 2014
31. Total Cardiac Monitoring Industry: Patient Continuum, US, 2014
32. Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013–2015



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.